DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Bought by Quantinno Capital Management LP

Quantinno Capital Management LP grew its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 276.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 116,808 shares of the medical instruments supplier’s stock after buying an additional 85,787 shares during the period. Quantinno Capital Management LP’s holdings in DENTSPLY SIRONA were worth $3,161,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also made changes to their positions in XRAY. UMB Bank n.a. boosted its holdings in DENTSPLY SIRONA by 430.3% in the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after purchasing an additional 753 shares in the last quarter. Capital Performance Advisors LLP acquired a new position in shares of DENTSPLY SIRONA in the 3rd quarter valued at $27,000. LRI Investments LLC grew its position in shares of DENTSPLY SIRONA by 82.7% in the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after buying an additional 564 shares during the last quarter. Kennebec Savings Bank acquired a new stake in DENTSPLY SIRONA during the 3rd quarter worth $35,000. Finally, Rothschild Investment LLC purchased a new stake in DENTSPLY SIRONA in the second quarter valued at $32,000. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Stock Performance

Shares of XRAY opened at $19.45 on Tuesday. The stock has a market capitalization of $3.87 billion, a P/E ratio of -9.40, a P/E/G ratio of 1.87 and a beta of 0.97. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA Inc. has a 1 year low of $17.21 and a 1 year high of $37.60. The company’s fifty day moving average is $21.71 and its two-hundred day moving average is $24.38.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. The business had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business’s revenue was up .4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.49 earnings per share. On average, sell-side analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on XRAY shares. Leerink Partnrs lowered DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Mizuho assumed coverage on DENTSPLY SIRONA in a research note on Wednesday, December 4th. They set a “neutral” rating and a $21.00 price target on the stock. Barrington Research reduced their price objective on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday, November 8th. StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Tuesday, November 19th. Finally, Needham & Company LLC reduced their price target on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a research report on Friday, October 25th. Eight research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $28.40.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.